February 28, 2023: Hallux Reaches Enrollment Target in Onychomycosis Trial


September 22, 2022: Hallux Inc Opens Third Clinical Site to Evaluate Novel Onychomycosis Product Candidate


July 7, 2022: Hallux Inc Opens Second Clinical Site to Evaluate Novel Onychomycosis Product Candidate


May 18, 2022: Seth M. Birnbaum Joins Pharma Company Hallux Inc. Board of Directors


April 6, 2022: Hallux Inc. Announces Closing Of $9.4M Series A-2 Financing


January 12, 2022: Hallux Starts Phase 2 Clinical Study Of Novel Subungual Gel For Onychomycosis


November 8, 2016: Hallux Announces Start of Phase 2 Clinical Trial